Analyses across different populations have demonstrated that APOE2 is associated with increased risk for AMD (odds ratio 1.124–1.83), while APOE4 is associated with reduced risk (odds ratio 0.43–0.81) [26,29,30,31,32]. This evidence concerns the gene APOE and age-related macular degeneration.